- Home
- VFS vs RGEN Comparison
VFS vs RGEN Comparison
Compare VFS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFS
- RGEN
- Stock Information
- Founded
- VFS 2017
- RGEN 1981
- Country
- VFS Vietnam
- RGEN United States
- Employees
- VFS N/A
- RGEN N/A
- Industry
- VFS Blank Checks
- RGEN Medical/Dental Instruments
- Sector
- VFS Finance
- RGEN Health Care
- Exchange
- VFS Nasdaq
- RGEN Nasdaq
- Market Cap
- VFS 8.2B
- RGEN 8.0B
- IPO Year
- VFS N/A
- RGEN N/A
- Fundamental
- Price
- VFS $3.64
- RGEN $127.47
- Analyst Decision
- VFS Buy
- RGEN Buy
- Analyst Count
- VFS 3
- RGEN 12
- Target Price
- VFS $5.75
- RGEN $170.40
- AVG Volume (30 Days)
- VFS 630.0K
- RGEN 685.0K
- Earning Date
- VFS 06-09-2025
- RGEN 07-29-2025
- Dividend Yield
- VFS N/A
- RGEN N/A
- EPS Growth
- VFS N/A
- RGEN N/A
- EPS
- VFS N/A
- RGEN N/A
- Revenue
- VFS $2,103,991,902.00
- RGEN $650,429,000.00
- Revenue This Year
- VFS N/A
- RGEN $13.93
- Revenue Next Year
- VFS $40.04
- RGEN $14.35
- P/E Ratio
- VFS N/A
- RGEN N/A
- Revenue Growth
- VFS 65.72
- RGEN 4.88
- 52 Week Low
- VFS $2.56
- RGEN $102.97
- 52 Week High
- VFS $5.38
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- VFS 56.15
- RGEN 54.11
- Support Level
- VFS $3.50
- RGEN $121.44
- Resistance Level
- VFS $3.75
- RGEN $131.43
- Average True Range (ATR)
- VFS 0.14
- RGEN 4.47
- MACD
- VFS 0.02
- RGEN 0.61
- Stochastic Oscillator
- VFS 73.17
- RGEN 74.57
About VFS VinFast Auto Ltd.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.